Trial intelligence / Profile preview

Autologous Adipose Cells Therapy for Skin Rejuvenation and Hair Improvement

NCT06869252Phase 2Recruiting

Sponsor
CERM
Start
Aug 2025
Primary completion
Nov 2025
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in Skin aging and alopecia, sponsored by CERM. Primary endpoints: Outcome Comparison Survey, Participant Satisfaction Survey and 3 more. Started Aug 2025; status: recruiting.

02

Conditions

Skin agingalopecia

Beyond the preview

Go deeper on NCT06869252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06869252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call